$ATNM Summary for ATNM Newbies: *ATNM Investor Presentation: d1io3yog0oux5.cloudfront.ne... *The Iomab-B SIERRA clinical trial Ad Hoc Analysis option was exercised during Q2 2020, results due 2H 2020 *CEO Seth: "We look forward to updates from all 3 trials by year end" *$53,000,000 cash June 30, Market Cap is only $138,000,000 *ATNM recently executed 1 for 30 reverse stock split *Outstanding shares now only 14 million *Insiders filed 8 SEC Form 4 for stock option purchases August 14 *ATNM has some $40+ analyst price targets for a very good pipeline tipranks.com/stocks/atnm/fo... *Actimab-A CLAG-M Combo Phase 1 trial successful ir.actiniumpharma.com/press... *Actimab A has multiple pending catalysts 2H 2020 ir.actiniumpharma.com/press... *More Institutional buying: Two Sigma added 23k shares in Sept. *There are now 52 Institutional filings for ATNM purchases since July & only 8 filings since July for sales. Why are BlackRock, Vanguard, Citadel, etc buying now?
  • 10